Has Scott Baron, MD received payments from drug or device companies?

Yes. Drug and device makers reported $347,929 in general payments to Scott Baron, MD across 694 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Baron, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Baron, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Baron, MD

Interventional Cardiology · Carmichael, CANPI 1215038930

Payments from drug & device makers

$347,929in general payments, 2019–2025

Across 694 payments — averaging $501.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$128K
Akcea Therapeutics, Inc.$80K
Novartis$51K
Amgen$40K
Pfizer$13K
Lexicon Pharmaceuticals, Inc.$9K
plus $27K from 37 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	123	$128,360
Akcea Therapeutics, Inc.	13	$80,052
Novartis	31	$50,983
Amgen	78	$39,580
Pfizer	37	$12,760
Lexicon Pharmaceuticals, Inc.	12	$9,174
E.r. Squibb & Sons, L.L.C.	34	$6,126
Abbott	13	$5,865
AstraZeneca	30	$4,122
Medtronic(2 entities)	94	$4,028
Sanofi-aventis U.S. LLC	24	$2,195
Boston Scientific	24	$597
Johnson & Johnson	37	$510
Abiomed	13	$358
Inari Medical, Inc.	6	$324
Novo Nordisk	11	$278
Actelion Pharmaceuticals US, Inc.	10	$272
Boehringer Ingelheim	15	$249
Shockwave Medical, Inc	12	$243
Bayer	9	$225
Amarin Pharma, Inc.	20	$225
Philips North America LLC	4	$207
W. L. Gore & Associates, Inc.	2	$175
Kestra Medical Technology Services, Inc.	1	$167
Cvrx, Inc.	1	$109
Esperion Therapeutics, Inc.	6	$88
Kiniksa Pharmaceuticals, Ltd.	4	$85
United Therapeutics Corporation	4	$81
Regeneron Healthcare Solutions, Inc.	3	$65
Portola Pharmaceuticals, LLC	1	$64
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$60
Arbor Pharmaceuticals, Inc.	2	$37
Bardy Diagnostics, Inc.	1	$34
Edwards Lifesciences	2	$31
Janssen Scientific Affairs, LLC	2	$29
Chiesi USA, Inc.	2	$27
Livanova USA, Inc.	1	$27
Kowa Pharmaceuticals America, Inc.	2	$26
Angiodynamics, Inc.	2	$20
Biotronik Inc.	1	$19
Gilead	1	$19
Heartflow, Inc.	1	$16
Cathworks, Inc.	1	$14

How this compares

$347,929 in reported general payments places this provider in the 90th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024

$406,550

Medicare patients

782

Services billed

3,733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Carmichael

Rajendra MakkarWest Hollywood$16.6M
Fahed BitarCovina$9.9M
Rahul SharmaStanford$6.6M
Matthew Pricela Jolla$5.8M
David LeeStanford$5.7M
Saibal KarThousand Oaks$5.4M
Mehrdad ArianiNorthridge$5M
Frederick St GoarMountain View$4.2M
Sammy ElmariahSan Francisco$4.2M
William FearonStanford$3.7M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →